FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gastroenterology, and can be used for prediction of development of non-alcoholic fatty liver disease. Body weight index, epicardial adipose tissue thickness, intra-abdominal fat thickness are measured, thickness of the posterior wall of the left ventricle of heart and index of insulin resistance HOMA-IR. A prognostic index is calculated by formula: K = -24.9 + 0.81 × BMI + 1.06 × TEAT + 0.02 × TIAT + 0.6 × TLLPW -1.07 × HOMA-IR, where K is the prognostic index; BMI - body weight index, units; TEAT - thickness of epicardial adipose tissue, mm; TIAT - thickness of intraabdominal adipose tissue, mm; TLLPW - thickness of posterior wall of left ventricle of heart, mm; HOMA-IR - insulin resistance index, units If K is lower than 9.37 units, a low risk of non-alcoholic fatty liver disease is predicted. If K is within 9.37 ≤ K ≤ 15.38 units predict an average risk of developing non-alcoholic fatty liver disease. If K is more than 15.38 units, a high risk of non-alcoholic fatty liver disease is predicted.
EFFECT: method provides predicting development of non-alcoholic fatty liver disease by calculating a prognostic index.
1 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN OF THE EUROPEAN POPULATION DURING SCREENING EXAMINATIONS | 2021 |
|
RU2760092C1 |
DIAGNOSTIC TECHNIQUE FOR INSULIN RESISTANCE | 2014 |
|
RU2553943C1 |
METHOD FOR PREDICTING THE RISK OF LIVER FIBROSIS IN PATIENTS WITH OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2794862C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
METHOD OF DIAGNOSING VISCERAL ADIPOPEXIS BY METHOD OF ECHOCARDIOGRAPHY IN CHILDREN AND TEENAGERS | 2009 |
|
RU2427319C2 |
METHOD OF DIAGNOSING METABOLIC SYNDROME | 2010 |
|
RU2444298C1 |
Authors
Dates
2020-04-01—Published
2018-07-23—Filed